Related Experiment Video
Updated: Oct 18, 2026
A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
Published on: July 17, 2012
Cytokines in myocardial injury: impact on cardiac surgical approach
1Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, People's Republic of China. swan@cuhk.edu.hk
Insights
Myocardial ischemia-reperfusion injury during cardiac surgery involves inflammation and cytokine release, particularly interleukin-8 (IL-8). Strategies like off-pump surgery or improved cardiopulmonary bypass circuits may reduce IL-8 and myocardial damage.
Area of Science:
- Cardiovascular Surgery
- Inflammation Biology
- Biomedical Engineering
Background:
- Myocardial ischemia-reperfusion injury is an acute inflammatory process critical in cardiac surgery.
- Activated leukocytes and endothelial cells, driven by cytokine release during cardiopulmonary bypass (CPB), play key roles.
- Interleukin-8 (IL-8) produced locally in the heart can exacerbate leukocyte activation and myocardial injury.
Purpose of the Study:
- To investigate the role of IL-8 in myocardial injury following coronary artery bypass grafting (CABG).
- To evaluate the impact of different surgical techniques and CPB circuit modifications on IL-8 production and myocardial damage.
Main Methods:
- Correlation analysis between postoperative cardiac troponin-I levels (myocardial injury marker) and IL-8 values in CABG patients.
- Comparison of IL-8 production and myocardial injury in patients undergoing off-pump CABG versus conventional CABG.
- Assessment of IL-8 and cardiac troponin-I levels following the use of heparin-coated CPB circuits.
Main Results:
- Postoperative cardiac troponin-I levels strongly correlated with IL-8 values in CABG patients.
- Off-pump CABG was associated with significantly less IL-8 production compared to conventional procedures, potentially reducing myocardial injury.
- Reduced IL-8 and cardiac troponin-I release was observed with heparin-coated CPB circuits.
Conclusions:
- IL-8 is a significant mediator of myocardial injury in the context of cardiac surgery and CPB.
- Modifications such as off-pump surgery and improved CPB biocompatibility (e.g., heparin-coated circuits) can mitigate IL-8 release and myocardial damage.
- Future therapeutic strategies should focus on minimizing the inflammatory response to improve myocardial preservation during cardiac surgery.
Abstract:
Myocardial ischemia-reperfusion injury associated with cardiac surgery is an acute inflammatory process in which activated leukocytes and endothelial cells play a critical role. Recent data indicate that the release of cytokines is crucial in inducing leukocytes and endothelial cells activation during cardiopulmonary bypass (CPB). Some inflammatory cytokines can be produced locally from the heart, particularly interleukin (IL)-8, which may further enhance leukocyte activation and accumulation in the injured myocardium. In fact, postoperative levels of cardiac troponin-I, a highly specific marker of myocardial injury, correlated strongly with IL-8 values in patients undergoing coronary artery bypass grafting (CABG). Off-pump CABG is associated with less IL-8 production compared with conventional procedure, which may in turn reduce the degree of myocardial injury. On the other hand, reduced release of IL-8 and cardiac troponin-I has also been discovered following the use of heparin-coated CPB circuits. In addition, the balance between pro- and anti-inflammatory mediators may be even more crucial in determining the extent of injury. Hence, avoiding the use of CPB or improving the biocompatibility of CPB may lead to better myocardial preservation. Research along these lines is expected to help in the development of ideal therapeutic strategies to minimize the inflammatory response and subsequent myocardial injury associated with cardiac surgery.
Related Concept Videos
01:21Myocarditis I: Introduction
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management